In addition to showing that NOX2 deficient neutrophils are effective cells in inflammasome-independent cleavage of pro-IL-1β, our results suggest the potential use of IL-1β-blocking agents as adjunctive therapies with antimicrobial agents in TB treatment. This evidence concerns the gene IL1B and tuberculosis.